Neonc Technologies Holdings, Inc. (NTHI)
$2.66+2.31%Close
SELLCRISIS · day 27
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $53M
- Beta
- 0.50
- P/E (TTM)
- -1.20
- Short % float
- 17.19%
- Days to cover
- 3.9
- SI change
- +45.1%
- 1W
- -1.85%
- 1M
- -19.64%
- vs SPY 1W
- -1.71%
- vs SPY 1M
- -22.14%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 14
- VALUE
- 12
- GROWTH
- 35
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC185.5%
REV YoY-
ROE309.1%
EPS YoY-
ROA-
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-1.20
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B-3.54
P/FCF-
EV/EBITDA-1.72
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.14
ND/EBITDA-
BETA0.50
Company news
FAQ
- What is LOPJLB’s current signal on NTHI?
- LOPJLB’s latest quantitative signal on Neonc Technologies Holdings, Inc. (NTHI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NTHI in?
- Neonc Technologies Holdings, Inc. (NTHI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Neonc Technologies Holdings, Inc. (NTHI) do?
- NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.